Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Lotus Pharmaceuticals Inc. Stock Analysis LTUS
United States Health Care Nano Cap Lotus Pharmaceuticals, Inc. engages in the manufacture and distribution of pharmaceutical products in the People's Republic of China. The company is headquartered in Beijing, Beijing and currently employs 233 full-time employees. The company went IPO on 2012-05-15. The firm produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The firm's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The firm operated in two business segment Wholesales segment and Retail segment. The firm's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The firm mainly conducts its businesses in the domestic market and overseas markets.
Read More Lotus Pharmaceuticals Inc (LTUS) Chart
Key Statistics of Lotus Pharmaceuticals Inc (LTUS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
10.00KP/E Ratio (TTM)
0.0152 Week Range
Market Cap
9.52MAvg. Volume
15.09KDividend Yield
-Financial Metrics & Statements of Lotus Pharmaceuticals Inc (LTUS)
FAQ's for Lotus Pharmaceuticals Inc (LTUS)
- According to Musaffa’s Shariah screening methodology, Lotus Pharmaceuticals Inc (LTUS) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lotus Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Lotus Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Lotus Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Lotus Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Lotus Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.